Amgen Inc - Total Other Income Expense Net

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -0.415 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2024.

Amgen Inc's third quarter result of 1.40 Billion USD for the item "Total Other Income Expense Net" represents an increase of 229.65 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 1.40 Billion USD for the item "Total Other Income Expense Net" represents an increase of 32.35 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of -0.415 Billion USD for the item "Total Other Income Expense Net" represents an increase of 45.11 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.12 Billion United States Dollars compared to the value the year prior.
The 1 year change is 1.12 Billion United States Dollars.
The 3 year change is 1.50 Billion United States Dollars.
The 5 year change is 0.525 Billion United States Dollars.
The 10 year change is 0.13 Billion United States Dollars.

The Serie's long term average value is -0.795 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.38 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is +2.25 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -0.541 Billion.